CLINICAL_TRIALS
trial_result
· 2011-05-16
Clinical Trial Update: PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia [Phase 2]
Summary
Phase 2 randomized trial comparing PH-797804 to placebo for neuropathic pain in postherpetic neuralgia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Neuralgia, Postherpetic | Phase 2 | Status: COMPLETED